Neufeld, Lena http://orcid.org/0000-0002-8229-9856
Yeini, Eilam
Pozzi, Sabina http://orcid.org/0000-0002-6299-9273
Satchi-Fainaro, Ronit http://orcid.org/0000-0002-7360-7837
Article History
Accepted: 12 September 2022
First Online: 24 October 2022
Competing interests
: R.S.F. declares that she is a Director on the board of Teva Pharmaceutical Industries and receives research funding from Merck for work unrelated to this manuscript. All other authors declare no competing interests.